The world's scientific and social network for malaria professionals
Subscribe to free Newsletter | 10491 malaria professionals are enjoying the free benefits of MalariaWorld today

monitoring

Monitoring of efficacy, tolerability and safety of artemether–lumefantrine and artesunate–amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Lambaréné, Gabon: an open-label clinical trial

December 17, 2019 - 16:46 -- Open Access
Author(s): 
Bayode R. Adegbite, Jean R. Edoa, Ayola A. Adegnika, et al.
Reference: 
Malaria Journal 2019 18:424, 16 December 2019

Malaria remains a major public health problem, affecting mainly low-and middle-income countries. The management of this parasitic disease is challenged by ever increasing drug resistance. This study, investigated the therapeutic efficacy, tolerability and safety of artemether–lumefantrine (AL) and artesunate–amodiaquine (AS–AQ), used as first-line drugs to treat uncomplicated malaria in Lambaréné, Gabon.

M&E of Malaria Programs E-learning Course Launched

December 13, 2012 - 19:10 -- Gretchen Bitar


MEASURE Evaluation, a USAID-funded project, is excited to announce the launch of the M&E of Malaria Programs e-course.

M&E of Malaria Programs provides an overview of fundamental concepts of monitoring and evaluation as they specifically relate to malaria prevention and control programs. It provides an overview of:

Subscribe to RSS - monitoring